AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33325344 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics (Group 3)
Number of subjects: 155
Study 33325344 — intervention group
Group type: COMPARATOR
Intervention: No postoperative antibiotics (Group 1)
Number of subjects: 155
Study 33325344 — intervention group
Group type: COMPARATOR
Intervention: No postoperative antibiotics (Group 2)
Number of subjects: 155
Study 35950355 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 89
Study 35950355 — intervention group
Group type: EXPERIMENTAL
Intervention: Supragingival scaling with vitamin C
Number of subjects: 89
Study 35950355 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C
Number of subjects: 89
Study 33441099 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise (2 circuits of resistance exercise: 6 exercises with 10 repetitions at 65-70% of one repetition maximum)
Number of subjects: 30
Study 33441099 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise (30 minutes running at 65-70% of maximal heart rate)
Number of subjects: 30
Study 33441099 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study 32931457 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based relaxation technique (YBRT) practiced 1 hour a day for 4 weeks
Number of subjects: 22
Study 32931457 — intervention group
Group type: COMPARATOR
Intervention: Control group maintaining usual physical activity regimen
Number of subjects: 22
Study 36031616 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 81
Study 36031616 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 81
Study 32046765 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus IPS (experimental condition)
Number of subjects: 832
Study 32046765 — intervention group
Group type: COMPARATOR
Intervention: TAU (control condition)
Number of subjects: 832
Study 36261422 — intervention group
Group type: EXPERIMENTAL
Intervention: Elated mental imagery condition
Number of subjects: 61
Study 36261422 — intervention group
Group type: COMPARATOR
Intervention: Calm mental imagery condition
Number of subjects: 61
Study 34239940 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (dapagliflozin 5 mg to 10 mg and empagliflozin 10 mg to 25 mg)
Number of subjects: 70
Study 34239940 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral antihyperglycemic drugs (OADs)
Number of subjects: 70
Study 33078388 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 2749
Study 33078388 — intervention group
Group type: COMPARATOR
Intervention: Opioids
Number of subjects: 2749
Study 33078388 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 2749
Study 33078388 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 2749
Study 36775516 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish Massage Therapy (SMT) for 12 weeks
Number of subjects: 47
Study 36775516 — intervention group
Group type: COMPARATOR
Intervention: Swedish Massage Therapy (SMT) for 6 weeks followed by 6 weeks of light touch (LT)
Number of subjects: 47
Study 36775516 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish Massage Therapy (SMT)
Number of subjects: 47
Study 33385318 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of dapoxetine hydrochloride
Number of subjects: 80
Study 33385318 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of dapoxetine hydrochloride
Number of subjects: 80
Study 32017646 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinkable collagen supplement containing special collagen peptides, acerola extract, vitamin C, vitamin E, biotin, and zinc for 12 weeks
Number of subjects: 60
Study 32017646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32017646 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinkable collagen supplement
Number of subjects: 60
Study 34293034 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Video Feedback (PVF)
Number of subjects: 288
Study 34293034 — intervention group
Group type: COMPARATOR
Intervention: Standard Instructor Feedback (SIF)
Number of subjects: 288
Study 35814411 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastrectomy plus jejunal interposition (PG+JI)
Number of subjects: 100
Study 35814411 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastrectomy plus esophagogastrostomy (PG+EG)
Number of subjects: 100
Study 35814411 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy plus Roux‐en‐Y esophagojejunostomy (TG+RY)
Number of subjects: 100
Study 35814411 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 100
Study 33591137 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 72
Study 33591137 — intervention group
Group type: COMPARATOR
Intervention: Epidural block (EB)
Number of subjects: 72
Study 32361367 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based Scheduled Gradual Reduction (SGR) intervention
Number of subjects: 98
Study 32361367 — intervention group
Group type: COMPARATOR
Intervention: Text-based support messages only (Control)
Number of subjects: 98
Study 35972218 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 13026
Study 35972218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13026
Study 33225983 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (5-day treatment)
Number of subjects: 204
Study 33225983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 33693713 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU daily
Number of subjects: 2385
Study 33693713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2385
Study 32932868 — intervention group
Group type: EXPERIMENTAL
Intervention: self-reported no-missed urine
Number of subjects: 2143
Study 32932868 — intervention group
Group type: EXPERIMENTAL
Intervention: creatinine index ≥0.7
Number of subjects: 2143
Study 32932868 — intervention group
Group type: EXPERIMENTAL
Intervention: mCER within 25% Kawasaki predicted urine creatinine
Number of subjects: 2143
Study 32932868 — intervention group
Group type: EXPERIMENTAL
Intervention: mCER within 15% Kawasaki predicted urine creatinine
Number of subjects: 2143
Study 32932868 — intervention group
Group type: EXPERIMENTAL
Intervention: sex-specific mCER ranges
Number of subjects: 2143
Study 35869615 — intervention group
Group type: EXPERIMENTAL
Intervention: Cylindrical abutment
Number of subjects: 25
Study 35869615 — intervention group
Group type: EXPERIMENTAL
Intervention: Concave abutment
Number of subjects: 25
Study 33630639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment with an emphasis on exercise (BT + PA)
Number of subjects: 320
Study 33630639 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment with an emphasis on exercise (ABT + PA)
Number of subjects: 320
Study 33630639 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral treatment (BT)
Number of subjects: 320
Study 33630639 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of MVPA
Number of subjects: 320
Study 35812198 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive sacral root magnetic stimulation (rSMS)
Number of subjects: 50
Study 35812198 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous posterior tibial nerve stimulation (TTNS)
Number of subjects: 50
Study 32124707 — intervention group
Group type: EXPERIMENTAL
Intervention: Connection Project intervention
Number of subjects: 610
Study 35309176 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanoid robot supervision of stretching exercises
Number of subjects: 27
Study 35309176 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapist supervision of stretching exercises (control)
Number of subjects: 27
Study 32340276 — intervention group
Group type: EXPERIMENTAL
Intervention: k‐Nearest Neighbors (kNN)
Number of subjects: 17
Study 32340276 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machines (SVM)
Number of subjects: 17
Study 32340276 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Networks (NN)
Number of subjects: 17
Study 32340276 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind source separation employing independent component analysis (ICA)
Number of subjects: 17
Study 32340276 — intervention group
Group type: EXPERIMENTAL
Intervention: Welch's method, autoregressive modeling, and discrete wavelet transform
Number of subjects: 17
Study 32340276 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal component analysis (PCA)
Number of subjects: 17
Study 35396952 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive exercise therapy
Number of subjects: 44
Study 35396952 — intervention group
Group type: COMPARATOR
Intervention: Non-intensive exercise therapy
Number of subjects: 44
Study 32340479 — intervention group
Group type: EXPERIMENTAL
Intervention: Similarity visual juxtaposition
Number of subjects: 0
Study 32340479 — intervention group
Group type: COMPARATOR
Intervention: Comparison juxtaposition
Number of subjects: 0
Study 32340479 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 32340479 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual juxtapositions (all types)
Number of subjects: 0
Study 32340479 — intervention group
Group type: EXPERIMENTAL
Intervention: Levels of surprise
Number of subjects: 0
Study 34768315 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal mediation analysis (CMA)
Number of subjects: 0
Study 33856424 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (active stimulation)
Number of subjects: 66
Study 33856424 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 66
Study 36043965 — intervention group
Group type: COMPARATOR
Intervention: F4 patch
Number of subjects: 54
Study 36043965 — intervention group
Group type: COMPARATOR
Intervention: F3 patch
Number of subjects: 54
Study 34774093 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based trauma-focused programme (Teaching Recovery Techniques), delivered by mental health practitioners both online and in-person
Number of subjects: 50
Study 34774093 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 50
Study 35360941 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (117 hips, 36.4% of cases)
Number of subjects: 371
Study 35360941 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment (remaining hips)
Number of subjects: 371
Study 35360941 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcome measures (PROMs)
Number of subjects: 371
Study 35360941 — intervention group
Group type: EXPERIMENTAL
Intervention: Late reossification stage (227 hips)
Number of subjects: 371
Study 33582379 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol (Intervention Group - IG)
Number of subjects: 120
Study 33582379 — intervention group
Group type: COMPARATOR
Intervention: Conventional recovery protocol (Control Group - CG)
Number of subjects: 120
Study 32659480 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice treatment with physiologic voice therapy plus vocal hygiene program (n=20)
Number of subjects: 34
Study 32659480 — intervention group
Group type: COMPARATOR
Intervention: Vocal hygiene program only (n=14)
Number of subjects: 34
Study 35995769 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine (DAC) + All-trans retinoic acid (ATRA)
Number of subjects: 0
Study 35995769 — intervention group
Group type: COMPARATOR
Intervention: Decitabine (DAC)
Number of subjects: 0
Study 35995769 — intervention group
Group type: COMPARATOR
Intervention: All-trans retinoic acid (ATRA)
Number of subjects: 0
Study 35995769 — intervention group
Group type: EXPERIMENTAL
Intervention: DAC + ATRA
Number of subjects: 0
Study 32562650 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfadoxine‐pyrimethamine
Number of subjects: 1617
Study 32562650 — intervention group
Group type: COMPARATOR
Intervention: dihydroartemisinin‐piperaquine
Number of subjects: 1617
Study 34179981 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVI
Number of subjects: 280
Study 34179981 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 280
Study 32649405 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Cosine R to T (TCRT) analysis in FMF patients
Number of subjects: 56
Study 32649405 — intervention group
Group type: COMPARATOR
Intervention: Total Cosine R to T (TCRT) analysis in control subjects
Number of subjects: 56
Study 32649405 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected average TCRT for heart rate in FMF patients
Number of subjects: 56
Study 32649405 — intervention group
Group type: COMPARATOR
Intervention: Corrected average TCRT for heart rate in control subjects
Number of subjects: 56
Study 32649405 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of FMF patients
Number of subjects: 56
Study 35277400 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coating balloon (DCB) angioplasty
Number of subjects: 784
Study 35277400 — intervention group
Group type: COMPARATOR
Intervention: Non-compliant balloon angioplasty
Number of subjects: 784
Study 36179423 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective learning based on visual mind mapping
Number of subjects: 80
Study 36179423 — intervention group
Group type: COMPARATOR
Intervention: Traditional reflective journal
Number of subjects: 80
Study 33711963 — intervention group
Group type: COMPARATOR
Intervention: Decompressive craniectomy (DC)
Number of subjects: 34
Study 33711963 — intervention group
Group type: EXPERIMENTAL
Intervention: DC plus head surface cooling (DCSC)
Number of subjects: 34
Study 33711963 — intervention group
Group type: EXPERIMENTAL
Intervention: DC plus endovascular hypothermia (DCEH)
Number of subjects: 34
Study 32036562 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA for 20 min)
Number of subjects: 102
Study 32036562 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1.5 mA for 20 min)
Number of subjects: 102
Study 32036562 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 20 min)
Number of subjects: 102
Study 32036562 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA for 20 min)
Number of subjects: 102
Study 32036562 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 102
Study 36510110 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention framed around the DOAC checklist, including three educational clinical pharmacist tele-visits, hotline access to the pharmacist, and coordination with continuity providers over 3 months.
Number of subjects: 561
Study 36510110 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 561
Study 34491647 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with fire needling therapy and acupoint application therapy
Number of subjects: 150
Study 34491647 — intervention group
Group type: COMPARATOR
Intervention: Acupoint application therapy
Number of subjects: 150
Study 34491647 — intervention group
Group type: COMPARATOR
Intervention: Western medication with pinaverium bromide tablets
Number of subjects: 150
Study 32787824 — intervention group
Group type: EXPERIMENTAL
Intervention: Menopause Rating Scale (MRS)
Number of subjects: 330
Study 36385642 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone infusion for up to 35 hours
Number of subjects: 9
Study 36385642 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion (placebo) for up to 35 hours
Number of subjects: 9
Study 34778188 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus nab-paclitaxel
Number of subjects: 0
Study 34778188 — intervention group
Group type: COMPARATOR
Intervention: Nab-paclitaxel
Number of subjects: 0
Study 32940404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumac (3 g/day) with restricted calorie diet (RCD)
Number of subjects: 62
Study 32940404 — intervention group
Group type: COMPARATOR
Intervention: Placebo with restricted calorie diet (RCD)
Number of subjects: 62
Study 35354633 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin added to usual care
Number of subjects: 0
Study 35354633 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32219407 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved basic preventive measures (sustained improvements in perioperative hand hygiene, vascular care, environmental cleaning, and patient decolonization efforts)
Number of subjects: 236
Study 32219407 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved basic preventive measures
Number of subjects: 236
Study 32219407 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 236
Study 36272891 — intervention group
Group type: EXPERIMENTAL
Intervention: MET + EMA
Number of subjects: 68
Study 36272891 — intervention group
Group type: COMPARATOR
Intervention: MET-only
Number of subjects: 68
Study 36272891 — intervention group
Group type: EXPERIMENTAL
Intervention: Momentary MAA
Number of subjects: 68
Study 33399374 — intervention group
Group type: EXPERIMENTAL
Intervention: 48 mg dexamethasone
Number of subjects: 64
Study 33399374 — intervention group
Group type: COMPARATOR
Intervention: 8 mg dexamethasone
Number of subjects: 64
Study 34653576 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB + IPACK block
Number of subjects: 120
Study 34653576 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB
Number of subjects: 120
Study 34653576 — intervention group
Group type: COMPARATOR
Intervention: IPACK block
Number of subjects: 120
Study 32931791 — intervention group
Group type: EXPERIMENTAL
Intervention: TETRA exposure at 6 W/kg
Number of subjects: 60
Study 32931791 — intervention group
Group type: EXPERIMENTAL
Intervention: GSM900 exposure at 2 W/kg
Number of subjects: 60
Study 32931791 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 60
Study 35188584 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hand exercise intervention
Number of subjects: 42
Study 35188584 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 33608735 — intervention group
Group type: EXPERIMENTAL
Intervention: In Vivo (experiential approach with sampling of NRTs)
Number of subjects: 83
Study 33608735 — intervention group
Group type: COMPARATOR
Intervention: Gold standard smoking cessation treatment (behavioral counseling plus self-selected combination NRT)
Number of subjects: 83
Study 32815832 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CT (120 kV)
Number of subjects: 8
Study 32815832 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate CT (100 kV)
Number of subjects: 8
Study 32815832 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT (80 kV)
Number of subjects: 8
Study 32815832 — intervention group
Group type: EXPERIMENTAL
Intervention: All CT protocols
Number of subjects: 8
Study 35248270 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) of the temporomandibular joint (TMJ)
Number of subjects: 20
Study 35248270 — intervention group
Group type: EXPERIMENTAL
Intervention: Molar shim (MS)
Number of subjects: 20
Study 35248270 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 20
Study 32917495 — intervention group
Group type: EXPERIMENTAL
Intervention: Red kidney beans
Number of subjects: 8
Study 32917495 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinto beans
Number of subjects: 8
Study 32917495 — intervention group
Group type: EXPERIMENTAL
Intervention: Black beans
Number of subjects: 8
Study 32917495 — intervention group
Group type: COMPARATOR
Intervention: Navy beans
Number of subjects: 8
Study 32917495 — intervention group
Group type: COMPARATOR
Intervention: Rice
Number of subjects: 8
Study 32510737 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 measurement at 2 months in ARISTOTLE trial
Number of subjects: 7389
Study 32510737 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 measurement at 3 months in RE-LY trial
Number of subjects: 7389
Study 32510737 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 measurement at study entry and at 2 months in ARISTOTLE trial
Number of subjects: 7389
Study 32510737 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 measurement at study entry, 3, 6, and 12 months in RE-LY trial
Number of subjects: 7389
Study 35172859 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept and/or Methotrexate (treatment withdrawal)
Number of subjects: 172
Study 33044440 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 12
Study 33044440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 32419117 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐Up (ABC) intervention
Number of subjects: 211
Study 32419117 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 211
Study 32419117 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster care placement
Number of subjects: 211
Study 32419117 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 211
Study 35956305 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning label (octagon with 'High in [nutrient]')
Number of subjects: 2869
Study 35956305 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic light label
Number of subjects: 2869
Study 35956305 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline Daily Amount (GDA)
Number of subjects: 2869
Study 35956305 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Rating (HSR)
Number of subjects: 2869
Study 35956305 — intervention group
Group type: COMPARATOR
Intervention: Control label (barcode)
Number of subjects: 2869
Study 33853187 — intervention group
Group type: EXPERIMENTAL
Intervention: ME-RP group
Number of subjects: 43
Study 33853187 — intervention group
Group type: EXPERIMENTAL
Intervention: no-ME-RP group
Number of subjects: 43
Study 35470087 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB) with multimodal analgesia
Number of subjects: 86
Study 35470087 — intervention group
Group type: COMPARATOR
Intervention: Control (standard postoperative multimodal analgesia)
Number of subjects: 86
Study 33165249 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical adhesive treatment after debridement without local anesthesia
Number of subjects: 180